Stem Cell Factor-Inducible MITF-M Expression in Therapeutics for Acquired Skin Hyperpigmentation

Area of Science:

• Molecular Biology
• Dermatology
• Cell Biology

Background:

• Microphthalmia-associated transcription factor M (MITF-M) is crucial for melanocyte function.
• SCF/KIT signaling impacts MITF-M activity via phosphorylation, reducing protein stability.
• Existing knowledge gaps concern SCF/KIT's role in MITF-M gene expression and therapeutic potential.

Purpose of the Study:

• To investigate if SCF/KIT regulates MITF-M via gene expression.
• To determine if KIT inhibition can reduce acquired skin pigmentation by targeting MITF-M expression.

Main Methods:

• Utilized melanocyte cultures (in vitro) and pigmented skin samples (in vivo).
• Employed techniques including immunoblotting, RT-PCR, siRNA gene knockdown, and confocal microscopy.
• Assessed MITF-M promoter activity and gene/protein expression levels.

Main Results:

• SCF/KIT stimulation induced de novo MITF-M expression at both mRNA and protein levels.
• SCF/KIT regulated MITF-M transcription via CREB, CRTC1, and SOX10, not β-catenin.
• KIT inhibition reduced SCF-induced melanin production and UV-B-induced hyperpigmentation, downregulating MITF-M expression.

Conclusions:

• SCF/KIT signaling directly induces MITF-M gene expression.
• Targeting SCF/KIT-inducible MITF-M expression is a potential therapeutic strategy for acquired pigmentary disorders.